摘要
目的通过分析颈动脉支架术患者血清中内皮型一氧化氮合酶(eNOS)的表达及血管内皮功能的改变,进一步探讨支架术后再狭窄的机制。方法将符合入组标准的患者根据是否有手术指征分为颈动脉支架组、颈动脉粥样硬化组。在入组前及术后1 h、1个月、6个月抽血采用ELISA测定血清eNOS,并测定血管内皮功能及颈动脉内膜中层厚度(IMT)。结果动脉粥样硬化组组内不同时间点血清eNos、IMT、血管舒张反应(FMD)比较差异无统计学意义(F=16.156,13.009,11.785,P>0.05);颈动脉支架组在支架置入后血清eNOS表达水平明显下降,FMD下降、颈动脉内膜厚度增厚,两组比较差异有统计学意义(F=104.521,176.501,167.116,P<0.05);阿托伐他汀治疗后血清eNOS表达水平上调,FMD上升、颈动脉内膜厚度下降并与剂量相关,差异有统计学意义(F=123.328,207.442,206.721,P<0.05);颈动脉支架组与动脉粥样硬化组比较差异有统计学意义(F=134.812,P<0.05)。结论 eNOS可以抑制颈动脉支架术后血管内膜的增生,减少再狭窄发生。
Objective To analyze the eNOS expression and endothelial function after carotid artery stenting in patients, and explore the mechanism of stent restenosis. Methods According to the indications of carotid stents, patients were divided to carotid atherosclerosis group and carotid artery stenting group. To measure the eNOS,endothelial function and the carotid artery IMT, at the beginning, 1 hour,1 month and 6 months of post-operative. Results The eNOS, IMT, vasodilation（FMD） of the carotid atherosclerosis group had no significant difference at different time points （F=16.156, 13.009, 11.785, P〉0.05）;After stent implantation the expression level of eNOS was significantly decreased FMD decreased, carotid artery intima-media thickness in the carotid artery stenting group, there was significant difference（F=104.521, 176.501, 167.116, P〈0.05）;The expression of eNOS and FMD were increased, carotid artery intima-media were thickness by atorvastatin and dose related its, there was significant difference（F=123.328, 207.442, 206.721, P〈0.05）;There was significant difference between the carotid artery stenting group and atherosclerosis group（F=134.812, P〈0.05）. Conclusion Endothelial nitric oxide synthase can inhibit carotid artery stenting intimal hyperplasia, reduce stent restenosis.
出处
《中华临床医师杂志（电子版）》
CAS
2014年第9期32-35,共4页
Chinese Journal of Clinicians(Electronic Edition)
基金
湖南省卫生厅资助科技项目(B2012-122)
关键词
一氧化氮合酶
颈动脉支架
血管内皮功能
颈动脉内膜
Nitric oxide synthase
Carotid artery stenting
Endothelial function
Carotid artery intima
